Novo Nordisk Inks $1.1B Deal For German Pharma Biz

By Josh White · March 25, 2024, 5:56 PM GMT

Danish pharmaceutical giant Novo Nordisk A/S said Monday it has signed a deal to acquire Cardior Pharmaceuticals of Germany for just over €1 billion ($1.1 billion) to widen its focus on...

To view the full article, register now.

Featured Stories

Biggest Rulings For Patent Attys In 2026: A Midyear Report No Photo Available

The U.S. Supreme Court clarified the pleading standard for induced infringement of skinny labels, and the Federal Circuit opened the d... (more story)

AI Notetakers For Doctors Raise 'Bycatching' Liability Risks No Photo Available

Busy doctors have embraced AI-powered devices that record patient conversations and generate visit notes. The expansion of ambient not... (more story)

Healthcare Deals This Week: AstraZeneca, Novartis, Vertex No Photo Available

Despite a short week, healthcare dealmakers were busy at work, as Law360 counted at least four billion-dollar transactions involving n... (more story)